Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 2/20 | 0.56 |
| ▸ | PDE5A | O76074 | 2/20 | 0.49 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | CDK2 | P24941 | 1/20 | 0.45 |
| ▸ | GSK3B | P49841 | 1/20 | 0.45 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.45 |
| ▸ | CSF1R | P07333 | 2/20 | 0.44 |
| ▸ | S100A4 | P26447 | 1/20 | 0.44 |
| ▸ | F12 | P00748 | 1/20 | 0.44 |
| ▸ | PLAU | P00749 | 1/20 | 0.44 |
| ▸ | NCF1 | P14598 | 1/20 | 0.44 |
| ▸ | NOS3 | P29474 | 1/20 | 0.44 |
| ▸ | NOS1 | P29475 | 1/20 | 0.44 |
| ▸ | NOS2 | P35228 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13367494 | 0.90 | PDE5A (0.48) | EGFRPDE5ACYP2A6S100A4CNR2 | |
| SCHEMBL13367553 | 0.89 | CYP2A6 (0.55) | EGFRCYP2A6S100A4F12PLAU | |
| SCHEMBL13367560 | 0.88 | CYP2A6 (0.49) | EGFRCYP2A6CDK2GSK3BDYRK1A | |
| SCHEMBL31098990 | 0.88 | CYP2A6 (0.49) | EGFRCYP2A6CDK2GSK3BDYRK1A | |
| SCHEMBL31098986 | 0.87 | S100A4 (0.43) | EGFRPDE5ACYP2A6S100A4F12 | |
| SCHEMBL3113118 | 0.84 | EGFR (0.57) | EGFRCSF1R | |
| SCHEMBL13367465 | 0.84 | CSF1R (0.53) | EGFRCYP2A6DYRK1ACSF1R | |
| SCHEMBL13367577 | 0.83 | CYP2A6 (0.47) | EGFRCYP2A6DYRK1ACSF1RS100A4 | |
| SCHEMBL13367444 | 0.83 | S100A4 (0.43) | EGFRPDE5ACYP2A6S100A4F12 | |
| SCHEMBL16484700 | 0.81 | PLAU (0.47) | CYP2A6S100A4F12PLAUNCF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112390755-B | Heteroaryl method for amine | 中国科学院理化技术研究所 | 2024-08-02 | — | — | CN | claimed |
| CN-112390755-B | Heteroaryl method for amine | 中国科学院理化技术研究所 | 2024-08-02 | — | — | CN | disclosed |
| CN-112390755-A | Method for heteroarylation of amine | 中国科学院理化技术研究所 | 2021-02-23 | — | — | CN | disclosed |
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OR10J3, OCIAD1, OCIAD2 | EGFR 1659/4885PDE5A 4323/4885CYP2A6 2286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.